We are live on
!
Find out more
CFG
Cambridge Financial Group Portfolio holdings
AUM
$267M
1-Year Est. Return
31.62%
This Fund
S&P 500
This Quarter
Est. Return
+5.32%
1 Year Est. Return
+31.62%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$198M
AUM Growth
–
Cap. Flow
+$184M
Cap. Flow
% of AUM
92.49%
Top 10 Holdings %
Top 10 Hldgs %
36.33%
Holding
30
New
30
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$7.26M |
| 2 |
Home Depot
HD
|
+$6.85M |
| 3 |
Masco
MAS
|
+$6.67M |
| 4 |
Citigroup
C
|
+$6.65M |
| 5 |
WBA
Walgreens Boots Alliance
WBA
|
+$6.64M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 24.38% |
| 2 | Financials | 24.27% |
| 3 | Industrials | 13.7% |
| 4 | Consumer Staples | 12.09% |
| 5 | Consumer Discretionary | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Regions Financial
RF
$26.4B
| $7.46M | 3.76% |
+745,273
| New | +$6.49M |
|
|
2
Biogen
BIIB
$30B
| $7.42M | 3.74% |
+33,997
| New | +$7.26M |
|
3
Lincoln National
LNC
$8.73B
| $7.32M | 3.69% |
+175,615
| New | +$5.99M |
|
4
Gilead Sciences
GILD
$162B
| $7.25M | 3.65% |
+117,999
| New | +$6.15M |
|
5
Boston Scientific
BSX
$69.5B
| $7.22M | 3.64% |
+661,329
| New | +$5.61M |
|
|
6
Citigroup
C
$222B
| $7.21M | 3.63% |
+138,268
| New | +$6.65M |
|
|
7
Home Depot
HD
$331B
| $7.21M | 3.63% |
+91,198
| New | +$6.85M |
|
8
Boeing
BA
$171B
| $7.15M | 3.6% |
+68,025
| New | +$6.46M |
|
9
Ford
F
$58.5B
| $7.01M | 3.53% |
+415,371
| New | +$5.96M |
|
|
WBA
10
DELISTED
Walgreens Boots Alliance
WBA
| $6.85M | 3.45% |
+136,307
| New | +$6.64M |
|
11
Ecolab
ECL
$78.1B
| $6.73M | 3.39% |
+73,039
| New | +$6.17M |
|
12
Johnson Controls International
JCI
$88.8B
| $6.7M | 3.38% |
+159,065
| New | +$5.94M |
|
13
Morgan Stanley
MS
$331B
| $6.7M | 3.38% |
+246,101
| New | +$5.84M |
|
|
14
Masco
MAS
$14.1B
| $6.69M | 3.37% |
+370,961
| New | +$6.67M |
|
15
CVS Health
CVS
$133B
| $6.66M | 3.36% |
+108,270
| New | +$6.27M |
|
16
Visa
V
$684B
| $6.66M | 3.36% |
+150,432
| New | +$6.58M |
|
17
General Dynamics
GD
$104B
| $6.65M | 3.35% |
+77,893
| New | +$5.8M |
|
18
Cardinal Health
CAH
$53.9B
| $6.52M | 3.28% |
+130,079
| New | +$5.94M |
|
19
Walt Disney
DIS
$167B
| $6.5M | 3.27% |
+100,470
| New | +$6.35M |
|
20
Bank of America
BAC
$435B
| $6.49M | 3.27% |
+444,849
| New | +$5.67M |
|
21
Amgen
AMGN
$208B
| $6.47M | 3.26% |
+59,758
| New | +$6.2M |
|
|
BMS
22
DELISTED
Bemis
BMS
| $6.43M | 3.24% |
+156,190
| New | +$6.2M |
|
23
Allstate
ALL
$68B
| $6.32M | 3.19% |
+123,992
| New | +$6.03M |
|
24
Archer Daniels Midland
ADM
$38.2B
| $6.31M | 3.18% |
+173,116
| New | +$5.78M |
|
25
Halliburton
HAL
$26.9B
| $6.16M | 3.1% |
+136,318
| New | +$5.7M |
|
Similar funds
EU
PC
ALC
TWM
IP
SP
EAIC
TGI
Cambridge Financial Group's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Cambridge Financial Group, which disclosed 30 positions worth $198M. Its ten largest holdings account for 36% of the portfolio.
Its largest position is Biogen: 33,997 shares worth $7.42M.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, followed by Financials and Industrials.
- Cambridge Financial Group's largest Q2 2013 buy was Biogen: 33,997 shares worth $7.42M.
- Cambridge Financial Group's ten largest holdings make up 36% of its $198M portfolio in Q2 2013.
- Cambridge Financial Group disclosed 30 positions in Q2 2013, its first 13F filing on record.
Based on Cambridge Financial Group's 13F filing for Q2 2013, filed 13 Aug 2013.